| Authors: |
Ewald JD; Imaging Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA; European Bioinformatics Institute, European Molecular Biology Laboratory, Hinxton, UK. Electronic address: jewald@ebi.ac.uk., Titterton KL; Axiom Bio, San Francisco, CA, USA., Bäuerle A; Axiom Bio, San Francisco, CA, USA., Beatson A; Axiom Bio, San Francisco, CA, USA., Boiko DA; Axiom Bio, San Francisco, CA, USA., Cabrera ÁA; Axiom Bio, San Francisco, CA, USA., Cheah J; The Center for the Development of Therapeutics, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Cimini BA; Imaging Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Gorissen BL; The Novo Nordisk Foundation Center for Genomic Mechanisms of Disease, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Harrill J; Center for Computational Toxicology and Exposure, Office of Research and Development, United States Environmental Protection Agency, Research Triangle Park, NC, USA., Jones TR; The Novo Nordisk Foundation Center for Genomic Mechanisms of Disease, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Karczewski KJ; The Novo Nordisk Foundation Center for Genomic Mechanisms of Disease, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Crute CE; Health and Environmental Sciences Institute, Washington, DC, USA., Rouquie D; Toxicology Data Science, Bayer SAS Crop Science Division, Sophia-Antipolis, Valbonne, France., Seal S; Imaging Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Weisbart E; Imaging Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA., White B; Axiom Bio, San Francisco, CA, USA., Carpenter AE; Imaging Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Singh S; Imaging Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA. |